45 related articles for article (PubMed ID: 37222086)
1. Treatment of feline intermediate to high-grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017-2021).
Moore AS; Frimberger AE
Vet Comp Oncol; 2024 Mar; 22(1):106-114. PubMed ID: 38152842
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Evaluation of Melphalan, Vincristine, and Cytarabine Chemotherapy for the Treatment of Relapsed Canine Lymphoma.
Duckett ME; Curran KM; Bracha S; Leeper HJ
J Am Anim Hosp Assoc; 2024 Jan; 60(1):7-14. PubMed ID: 38175982
[TBL] [Abstract][Full Text] [Related]
3. Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
Martin OA; Price J
J Feline Med Surg; 2018 Oct; 20(10):934-939. PubMed ID: 29065803
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of clinical response and prognostic factors in canine multicentric lymphoma treated with first rescue therapy.
Blaxill JE; Bennett PF
Vet Comp Oncol; 2024 Jun; 22(2):265-277. PubMed ID: 38646859
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.
Purvis KN; Swanson HD; Niloy KK; Zhou Y; Panetta JC; Crews KR; Flerlage JE
Cancer Chemother Pharmacol; 2023 Jul; 92(1):1-6. PubMed ID: 37199744
[TBL] [Abstract][Full Text] [Related]
6. Alternating rabacfosadine and doxorubicin for treatment of naïve canine lymphoma.
Saba CF; Fan TM; Phillips BS; Wright ZM; Thamm DH
Vet Comp Oncol; 2024 Jun; 22(2):278-283. PubMed ID: 38616055
[TBL] [Abstract][Full Text] [Related]
7. Novel Treatments for Lymphoma.
Thamm DH
Vet Clin North Am Small Anim Pract; 2024 May; 54(3):477-490. PubMed ID: 38199913
[TBL] [Abstract][Full Text] [Related]
8. Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma.
Siewert JM; Gustafson DL; Weishaar KM; Galloway AM; Thamm DH
J Vet Intern Med; 2023; 37(6):2402-2409. PubMed ID: 37787577
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles associated with early relapse during first remission induction in canine multicentric high-grade B-cell lymphoma.
Toyoda H; Tani A; Goto-Koshino Y; Motegi T; Sakamoto M; Mochizuki T; Harada K; Kobayashi T; Setoguchi A; Shizuta Y; Mizuno T; Irie M; Nakamichi J; Tsujimoto H; Ohmi A; Fukuoka R; Nakamura Y; Tomiyasu H
J Vet Med Sci; 2024 Jan; 86(1):18-27. PubMed ID: 37952972
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evaluation of probiotic effects on gastrointestinal signs in dogs with multicentric lymphoma undergoing multi-agent chemotherapy: A randomised, placebo-controlled study.
Jugan MC; Wouda RM; Higginbotham ML
Vet Rec Open; 2021 Dec; 8(1):e2. PubMed ID: 33981436
[TBL] [Abstract][Full Text] [Related]
11. L-LOP/LOPP for the treatment of canine gastrointestinal/hepatosplenic lymphoma.
Lai YY; Horta RDS; Almendros A; Ha PWY; Giuliano A
Front Vet Sci; 2024; 11():1373180. PubMed ID: 38846784
[TBL] [Abstract][Full Text] [Related]
12. Use of Lomustine and Prednisolone as First-Line Treatment in Canine Multicentric Lymphoma.
Chiara C; Luigi BM; Elisabetta T; Marta P; Katja R; Paola V
Vet Comp Oncol; 2024 Jun; ():. PubMed ID: 38890811
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of a rapid-escalation vinblastine-prednisolone protocol in dogs with mast cell tumours.
Serra Varela JC; Pecceu E; Handel I; Lawrence J
Vet Med Sci; 2016 Nov; 2(4):266-280. PubMed ID: 29067202
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Zimmerman K; Walsh KA; Ferrari JT; Keuler NS; Atherton MJ; Lenz JA
Vet Comp Oncol; 2023 Sep; 21(3):503-508. PubMed ID: 37222086
[TBL] [Abstract][Full Text] [Related]
15. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).
Rassnick KM; Mauldin GE; Al-Sarraf R; Mauldin GN; Moore AS; Mooney SC
J Vet Intern Med; 2002; 16(5):576-80. PubMed ID: 12322709
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combination l-asparaginase plus CHOP or modified MOPP treatment protocols in dogs with multi-centric T-cell or hypercalcaemic lymphoma.
Angelo G; Cronin K; Keys D
J Small Anim Pract; 2019 Jul; 60(7):430-437. PubMed ID: 30790291
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in cats.
MaloneyHuss MA; Mauldin GE; Brown DC; Veluvolu SM; Krick EL
J Feline Med Surg; 2020 Apr; 22(4):299-304. PubMed ID: 30994392
[TBL] [Abstract][Full Text] [Related]
18. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
